Pfizer to Buy Hospira in Deal Valued at About $17 Billion

donderdag 5 februari 2015 18:00

Pfizer Inc. agreed to buy Hospira Inc., the biggest provider of injectable drugs, in a transaction valued at about $17 billion, beefing up its roster of generic medicine ahead of a potential spinoff.(Bloomberg)